Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Fundamental & clinical pharmacology • 2007 | View Paper
“ AG treatment significantly decreased MDA, TOS and OSI levels and increased SOD, CAT, GPX and GSH levels, when compared to the RT‐treated groups in both kidney and testis tissue.”
“In the diabetic and nondiabetic groups, AG administration significantly reduced the MDA and NO levels and significantly increased GSH content and SOD enzyme activity.”
“Pretreatment with AG prevented CP-induced lipid peroxidation, protein oxidation, depletion of reduced GSH , and loss of activities of the antioxidant enzymes including GPx, catalase, and GSTase and also MPO activity.”
Redox report : communications in free radical research • 2011 | View Paper
“Compared to …, AG at the dosage of 150mg/kg induced a reduction in the permeability of blood-spinal cord barrier (BSCB) after injury 48h (from …/g to 39.8+/-3.8microl/g), a 38% decrease of Malondialdehyde (MDA) values and a 1-fold increase of the Glutathione ( GSH ) levels ….”
“Free radical level was significantly lowered, whereas reduced glutathione level was significantly increased by aminoguanidine treatment in the aortic tissues from SHR.”
Cell biochemistry and function • 2006 | View Paper
“In cortex AG decreases to a lower degree the concentration of Cys, CC, GSH but in this brain part significantly decreases ROS levels and increases SS.”